Brent Sullivan, MD
NPI 1710098173 · Urology Physician · Tampa, FL
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1710098173
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- ME69655 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
845 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 386 | $123 |
| Urinalysis, Manual Test81002 | 85 | $3 |
| Diagnostic Exam of Bladder and Urethra Using an Endoscope52000 | 82 | $227 |
| Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222 | 43 | $126 |
| Imaging of Urinary Tract Following Injection of a Contrast Agent74420 | 40 | $23 |
| Biopsy of Prostate Gland55700 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 248 | 86 |
| Finasteride | 147 | 55 |
| Cefdinir | 140 | 119 |
| Ciprofloxacin Hcl | 91 | 73 |
| Levofloxacin | 67 | 53 |
| Dutasteride | 62 | 26 |
| Bicalutamide | 62 | 32 |
| Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$106 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-31
- Last updated
- 2021-08-27
- Certified
- 2021-08-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.